NCT02047708View on ClinicalTrials.gov

Zibotentan Better Renal Scleroderma Outcome Study

PHASE2CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions

SclerodermaScleroderma Renal CrisisChronic Kidney Disease

Interventions

DRUG

Zibotentan

Selective endothelin-A antagonist

Trial Locations (1)

NW32QG

Royal Free London NHS Foundation Trust, London

Sponsors

Collaborators (1)

Medical Research Council

All Listed Sponsors

collaborator

Medical Research Council

OTHER_GOV

lead

University College, London

OTHER